Advanced Search

Home Health & Hospice Week

Amedisys Shuts Down Locations, Receives DOJ Investigation Demand.

Published on Wed Sep 01, 2010

The investigation into therapy provision practices at publicly traded companies appears to be taking its toll on Amedisys Inc. The Baton Rouge, La.-based national chain is closing or merging 39 locations and reducing its planned start-ups for this year from 40 to 10, the company says in a release. "The tremendous growth Amedisys has experienced over the last few years inevitably led to markets that could benefit from consolidation," COO Michael Snow says in the release. "This is a continuous process to enhance our infrastructure and adjust our operating culture." The company expects to incur charges of $7 to $9 million this year as a result of the closures, mergers, and start-up discontinuances, it says. It's not over: Amedisys has "received a civil investigative demand ("CID") issued by the U.S. Department of Justice pursuant to the federal False Claims Act," the company says in a separate release. "The CID requires [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Home Health & Hospice Week

View All